A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
Condition(s):Neuromyelitis Optica; Neuromyelitis Optica Spectrum DisorderLast Updated:October 16, 2023Active, not recruiting